New insights in bilirubin metabolism and their clinical implications
Open Access
- 1 January 2013
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 19 (38), 6398-407
- https://doi.org/10.3748/wjg.v19.i38.6398
Abstract
Bilirubin, a major end product of heme breakdown, is an important constituent of bile, responsible for its characteristic colour. Over recent decades, our understanding of bilirubin metabolism has expanded along with the processes of elimination of other endogenous and exogenous anionic substrates, mediated by the action of multiple transport systems at the sinusoidal and canalicular membrane of hepatocytes. Several inherited disorders characterised by impaired bilirubin conjugation (Crigler-Najjar syndrome type I and type II, Gilbert syndrome) or transport (Dubin-Johnson and Rotor syndrome) result in various degrees of hyperbilirubinemia of either the predominantly unconjugated or predominantly conjugated type. Moreover, disrupted regulation of hepatobiliary transport systems can explain jaundice in many acquired liver disorders. In this review, we discuss the recent data on liver bilirubin handling based on the discovery of the molecular basis of Rotor syndrome. The data show that a substantial fraction of bilirubin conjugates is primarily secreted by MRP3 at the sinusoidal membrane into the blood, from where they are subsequently reuptaken by sinusoidal membrane-bound organic anion transporting polypeptides OATP1B1 and OATP1B3. OATP1B proteins are also responsible for liver clearance of bilirubin conjugated in splanchnic organs, such as the intestine and kidney, and for a number of endogenous compounds, xenobiotics and drugs. Absence of one or both OATP1B proteins thus may have serious impact on toxicity of commonly used drugs cleared by this system such as statins, sartans, methotrexate or rifampicin. The liver-blood cycling of conjugated bilirubin is impaired in cholestatic and parenchymal liver diseases and this impairment most likely contributes to jaundice accompanying these disorders.Keywords
This publication has 98 references indexed in Scilit:
- Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasisHepatology, 2003
- The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†Drug Metabolism Reviews, 2001
- Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver DisordersSeminars in Liver Disease, 2000
- Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal PeriodPublished by Elsevier BV ,1996
- Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndromeHepatology, 1996
- Crigler‐Najjar type II disease inheritance: A family studyJournal of Inherited Metabolic Disease, 1989
- Crigler-Najjar syndrome type I: Treatment by home phototherapy followed by orthotopic hepatic transplantationThe Journal of Pediatrics, 1987
- Purification of UDP‐glucuronyltransferase from untreated rat liverFEBS Letters, 1977
- Abnormal Sulfobromophthalein Metabolism in Rotor's Syndrome and Obligate HeterozygotesNew England Journal of Medicine, 1977
- CHRONIC UNCONJUGATED HYPERBILIRUBINEMIA WITHOUT OVERT SIGNS OF HEMOLYSIS IN ADOLESCENTS AND ADULTS*JCI Insight, 1962